Remove Clinical Development Remove Development Remove Drug Trials
article thumbnail

Small Pharma stock market launch funds DMT-based depression drug trial

pharmaphorum

UK-based Small Pharma has launched on the Toronto’s TSX Venture Exchange, raising 58 million Canadian dollars (around £34m) to develop medicines based on N,N-dimethyltriptylene (DMT) to treat depression. The post Small Pharma stock market launch funds DMT-based depression drug trial appeared first on.

article thumbnail

Avacta opens two US sites and doses first patient in sarcoma drug trial

Outsourcing Pharma

TWO US clinical investigator sites have been opened for a phase 1 clinical trial for patients with soft tissue sarcoma and the first patient has been dosed.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Unlocking the potential in rare disease research with decentralised trials

pharmaphorum

A survey of members of the Raremark community found that 86% of respondents were interested in taking part in a clinical trial now or in the future. Research and development will always be important to rare disease patients. This is a key reason why patients view the continued progress of research and development as important.

Trials 133
article thumbnail

Building Inclusive Trials: Insights from CTTI’s Diversity Initiatives

XTalks

Historically, racial and ethnically minoritized groups or populations have been excluded from clinical trials, leading to a lack of data on how different demographic subgroups respond to treatments. It also develops trust in clinical trials results and facilitates uptake if a medical product is approved,” Mervin-Blake noted.

Trials 52
article thumbnail

Crucial Data Solutions Announces Updates to TrialKit AI, EHR to EDC API

Crucial Data Soutions

(CDS), a leading technology provider focused on data collection and clinical trial management, today announced several updates in celebration of its tenth anniversary, including the company’s latest technological development, TrialKit AI, a machine-learning API. 888) 753-4777 carley.nolan@crucialdatasolutions.com.

article thumbnail

Scepticism in press over Kintor’s COVID-19 US drug trial

pharmaphorum

China’s Kintor Pharmaceutical has begun late-stage US clinical development of its potential COVID drug proxalutamide – but there is scepticism over the company’s claims about its research. The post Scepticism in press over Kintor’s COVID-19 US drug trial appeared first on.

article thumbnail

Steps to building a more patient-centric industry

pharmaphorum

As the industry focuses on creating a more holistic, inclusive patient experience, here are key steps to consider in order to help bridge the gap between clinical research and the patient experience. The fact is, many minorities never learn about vital clinical trials in play, or that they’re eligible to participate.